FDA
approval
· 2017-04-27
FDA Approved: SUPRANE — Supplemental Application (Baxter Healthcare Corporation)
Summary
The FDA approved a supplemental application for SUPRANE (desflurane) by Baxter Healthcare Corporation.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for SUPRANE (DESFLURANE)